T
Overview
Tessan develops AI-assisted telemedicine hardware and services that enable remote medical consultations in France. Its products—consultation booths, kiosks, medical bags, and exam tables—are deployed in pharmacies, retirement homes, and communities to connect patients with doctors. The system supports telemedicine across specialties such as tele-ophthalmology and dermatology, using connected diagnostic tools for remote assessments. With over 1,600 health professionals across more than 500 locations and more than 2 million patients served, Tessan aims to broaden access to care by combining practical devices with a nationwide professional network.
Work here?Claim your company
Simplify's take
What believers are saying
- DoctorBox's June 2026 deal opens Germany after a new 30-euro reimbursement.
- Tessan continues serving 1,700 pharmacies despite receivership, preserving installed-base revenue.
- The company is piloting telemedicine kiosks in Florida and New York.
What critics are saying
- Paris court opened redressement judiciaire on April 28, 2026 after cash strain.
- CEO blamed rapid expansion and fragile profitability, threatening restructuring or liquidation.
- September 2026 backlash over paid queue-jumping damaged trust with patients and pharmacists.
What makes Tessan unique
- Tessan pairs teleconsultation booths with seven-device clinical exams inside pharmacies.
- DoctorBox partnered with Tessan on June 3, 2026 for German pharmacy telemedicine.
- Tessan claims 1,700+ deployed sites and 2 million patients across France and Europe.
Help us improve and share your feedback! Did you find this helpful?